Evaluating bone marrow dosimetry with the addition of bone marrow structures to the medical internal radiation dose phantom

Abstract

Reliable estimates of radiation dose to bone marrow are critical to understanding the risk of radiation‐induced cancers. Although the medical internal radiation dose phantom is routinely used for dose estimation, bone marrow is not defined in the phantom. Consequently, methods of indirectly estimating bone marrow dose have been implemented based on dose to surrogate volumes or average dose to soft tissue.